Lu Liu, Jian Huang
Abstract: Background: Sepsis-induced
cardiomyopathy (SICM), a significant cardiovascular complication of sepsis,
necessitates prompt and effective management. While timely antimicrobial
treatment forms the bedrock of early sepsis management, the relationship
between the timing of piperacillin/tazobactam administration and the
development of SICM remains incompletely characterized. Objectives: The primary
objective of this study was to investigate the association between early
piperacillin/tazobactam administration and SICM incidence and short-term
outcomes. A secondary objective was to identify factors associated with SICM
and to develop an exploratory model for its prediction. Methods: This
single-center, retrospective observational study included 149 adults with
sepsis admitted between January 2023 and January 2026. Patients were
categorized into two groups: Early treatment (≤1 h; n=68) or delayed treatment
(>1 h; n=81). SICM was assessed using echocardiographic criteria. Clinical
outcomes were compared using univariate and multivariable logistic regression.
Internal validation was performed using 1,000 bootstrap resamples. Results: SICM occurred in 15/68 (22.06%) early-treatment patients and 33/81
(40.74%) delayed-treatment patients (P=0.014). Twenty-eight-day mortality was
14.71% versus 29.63% (P=0.029) and ICU and total hospital stays were shorter in
the early-treatment group (both P<0.001). Delayed treatment (OR=2.354, 95%
CI 1.044–5.310), SOFA ≥8 (OR=2.762, 95% CI 1.215–6.279), NT-proBNP ≥1500 pg/mL
(OR=3.019, 95% CI 1.320–6.906) and each 0.1-ng/mL elevation in cTnI (OR=1.208,
95% CI 1.037–1.408) were independently linked to SICM. The model AUC was 0.842
(95% CI 0.776–0.908); Hosmer–Lemeshow P=0.409. Conclusion: Early
administration of piperacillin/tazobactam was associated with lower SICM
incidence and improved short-term outcomes. However, because this study is
retrospective, a causal relationship cannot be definitively established.
Furthermore, the exploratory prediction model developed warrants external
validation to confirm its generalizability and accuracy.

Cardiomyopathies
Piperacillin
Risk factors
Sepsis